HELRIK
Desconocido
CANCER: Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life
HELRIK AND LOUW COMPANY LTD
participó en un
H2020:
H2020-MSCA-RISE-2017
During this RISE project we aim to develop nanoparticle-based encapsulated libraries of different immunotherapeutic
biomolecules for treatme...
2017-11-21 - 2023-08-31 | Financiado
2017-11-21 - 2023-08-31 | Financiado
CHARMED: Characterisation Of A Green Microenvironment And To Study Its Impact Upon Health and Well Being in T...
HELRIK AND LOUW COMPANY LTD
participó en un
H2020:
H2020-MSCA-RISE-2016
Our society in Europe is still under prepared for the demographic changing situation of an ageing population which began several decades ago...
2016-12-14 - 2021-12-31 | Financiado
2016-12-14 - 2021-12-31 | Financiado
* No se disponen de datos de la empresa actual.